Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells
Open accessThe DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Abstract
Ovarian cancer is known as a serious malignancy that affects women’s reproductive tract and can considerably threat their health. A wide range of molecular mechanisms and genetic modifications have been involved in ovarian cancer pathogenesis making it difficult to develop effective therapeutic platforms. Hence, discovery and developing new therapeutic approaches are required. Medicinal plants, as a new source of drugs, could potentially be used alone or in combination with other medicines in the treatment of various cancers such as ovarian cancer. Among various natural compounds, quercetin has shown great anti-cancer and anti-inflammatory properties. In vitro and in vivo experiments have revealed that quercetin possesses a cytotoxic impact on ovarian cancer cells. Despite obtaining good results both in vitro and in vivo, few clinical studies have assessed the anti-cancer effects of quercetin particularly in the ovarian cancer. Therefore, it seems that further clinical studies may introduce quercetin as therapeutic agent alone or in combination with other chemotherapy drugs to the clinical setting. Here, we not only summarize the anti-cancer effects of quercetin but also highlight the therapeutic effects of quercetin in the ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“At present, dasatinib (D), a tyrosine-kinase inhibitor that is Food and Drug Administration (FDA)-approved for chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL)22, and quercetin (Q), a natural plant-derived flavonoid with anti-inflammatory, antioxidant and antineoplastic properties23 potentially by modulating autophagy24, are the best-characterized senolytics9.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Nwaeburu, C. C., Abukiwan, A., Zhao, Z., & Herr, I. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0589-8 · Cited by 114
RetractedNwaeburu, C. C., Bauer, N., Zhao, Z., Abukiwan, A., Gladkich, J., Benner, A., & Herr, I. (2016) · Oncotarget · doi:10.18632/oncotarget.11122 · Cited by 96
RetractedXi, L., Zhang, Y., Kong, S., & Liang, W. (2018) · Bioscience Reports · doi:10.1042/bsr20180078 · Cited by 27
RetractedPanche, A. N., Diwan, A. D., & Chandra, S. R. (2016) · Journal of Nutritional Science · doi:10.1017/jns.2016.41 · Cited by 5,298
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Antimicrobial activity of flavonoids
Cushnie, T. P. T., & Lamb, A. J. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.09.002 · Cited by 3,195
Rubin, M., & Stephen, C. D. (1993) · Cited by 3,149
Health effects of quercetin: From antioxidant to nutraceutical
Boots, A. W., Haenen, G. R. M. M., & Bast, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.008 · Cited by 2,121
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
Park, J.-H., Gu, L., von Maltzahn, G., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2009) · Nature Materials · doi:10.1038/nmat2398 · Cited by 1,897
Jayson, G. C., Kohn, E. C., Kitchener, H. C., & Ledermann, J. A. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62146-7 · Cited by 1,850
Cited by
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial
Gonzales, M. M., Garbarino, V. R., Kautz, T. F., Palavicini, J. P., Lopez-Cruzan, M., Dehkordi, S. K., Mathews, J. J., Zare, H., Xu, P., Zhang, B., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02543-w · Cited by 334
Orr, M., Gonzales, M., Garbarino, V., Kautz, T., Palavicini, J., Lopez-Cruzan, M., Dehkordi, S. K., Mathews, J., Zare, H., Xu, P., et al. (2023) · doi:10.21203/rs.3.rs-2809973/v1 · Cited by 319
Quercetin, a Flavonoid with Great Pharmacological Capacity
Carrillo-Martinez, E. J., Flores-Hernández, F. Y., Salazar-Montes, A. M., Nario-Chaidez, H. F., & Hernández-Ortega, L. D. (2024) · Molecules · doi:10.3390/molecules29051000 · Cited by 287
Quercetin: a natural compound for ovarian cancer treatment
Shafabakhsh, R., & Asemi, Z. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0530-4 · Cited by 231
Pharmacological Activity of Quercetin: An Updated Review
Wang, G., Wang, Y., Yao, L., Gu, W., Zhao, S., Shen, Z., Lin, Z., Liu, W., & Yan, T. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/3997190 · Cited by 224
Metadata
- Authors
- Vafadar, A., Shabaninejad, Z., Movahedpour, A., Fallahi, F., Taghavipour, M., Ghasemi, Y., Akbari, M., Shafiee, A., Hajighadimi, S., Moradizarmehri, S., Razi, E., Savardashtaki, A., & Mirzaei, H.
- Affiliations
- Shiraz University of Medical Sciences (IR)
- Tarbiat Modares University (IR)
- Kashan University of Medical Sciences (IR)
- Mazandaran University of Medical Sciences (IR)
- Toronto General Hospital (CA)
- Corresponding author
- Razi, Ebrahim
- Savardashtaki, Amir
- Mirzaei, Hamed
- ORCID
- Venue
- Cell & Bioscience
- Published
- 2020-03-10
- Volume
- 10
- Issue
- 1
- Pages
- 32-32
- ISSN
- 2045-3701 (ISSN-L)
- PMC
- PMC7063794
- OpenAlex
- W3011251699
- Cited by
- 296
- References
- 143
- Citations by year
- 2026: 21 · 2025: 30 · 2024: 45 · 2023: 59 · 2022: 77 · 2021: 46 · 2020: 16
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Cell & Bioscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Flavonoids in Medical Research
- Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Medicinal Plant Research
- Keywords
- quercetin, ovarian cancer, anticancer effects, cytotoxicity, medicinal plants, natural compounds, anti-inflammatory activity, combination chemotherapy, flavonoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells. https://app.cochat.ai/papers/10.1186/s13578-020-00397-0
- The paper
- Vafadar, A., Shabaninejad, Z., Movahedpour, A., Fallahi, F., Taghavipour, M., Ghasemi, Y., Akbari, M., Shafiee, A., Hajighadimi, S., Moradizarmehri, S., Razi, E., Savardashtaki, A., & Mirzaei, H. (2020). Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells. Cell & Bioscience. https://doi.org/10.1186/s13578-020-00397-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


